Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies

Wu, Lang, Zhu, Jingjing, Prokop, Larry J., Murad, Mohammad Hassan·2015·Scientific Reports
DOI 10.1038/srep10147

Cited by (144)

Items 101–144 of 144

  1. Cancer Prevention Strategies for Women
    Ana Isabel Tergas, Jason Dennis Wright · 2019 · Obstetrics and Gynecology
  2. Colon cancer modulation by a diabetic environment: A single institutional experience
    I. Prieto, Laura del Puerto‐Nevado, Nieves González, Sergio Portal‐Núñez, Sandra Zazo, Marta Cortón, Pablo Mínguez, Carmen Gómez‐Guerrero, José Miguel Sahuquillo-Arce, Ana Belen Sanz et al. · 2017 · PLoS ONE
  3. Cancer biology in diabetes update: Focusing on antidiabetic drugs
    Emi Kawakita, Keizo Kanasaki · 2024 · Journal of Diabetes Investigation
  4. Type 2 diabetes is an independent negative prognostic factor in patients undergoing surgical resection of a WHO grade I meningioma
    Arash Nayeri, Silky Chotai, Marc Prablek, Philip R. Brinson, Diana G. Douleh, Kyle D. Weaver, Reid C. Thompson, Lola Blackwell Chambless · 2016 · Clinical Neurology and Neurosurgery
  5. Pharmacotherapy of Diabetes Mellitus Type 2: A Review on Various Hypoglycemics
    Muhammad Khalid Khan, Rizwan Ullah Baig · 2022 · Journal of Clinical and Nursing Research
  6. Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study
    Mariusz Dąbrowski, Elektra Szymańska‐Garbacz, Zofia Miszczyszyn, Tadeusz Dereziński, Leszek Czupryniak · 2017 · Oncotarget
  7. Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
    Aurora Mirabile, Licia Rivoltini, Elena Daveri, Claudio Vernieri, Roberto Mele, Luca Porcu, Chiara Lazzari, Alessandra Bulotta, Maria Grazia Viganò, Stefano Cascinu et al. · 2020 · Cancers
  8. Metformin Exposure and Risk of Hypertensive Disorders of Pregnancy in Patients with Type 2 Diabetes
    Jenna L. Racine, Jacquelyn H. Adams, Kathleen M. Antony, Kara Kjersten Hoppe, Jesus Igor Iruretagoyena, Katharina S. Stewart, April Eddy, Janine S. Rhoades · 2021 · American Journal of Perinatology
  9. Association between antidiabetic drugs and cancer risk in patients with type 2 diabetes mellitus: A systematic review and network meta-analysis
    Xuedong An, Liyun Duan, Yuehong Zhang, Qian-You Jia, Yanmin Zhang, Yun Qiao · 2025 · World Journal of Diabetes
  10. The Warburg Trap: A Novel Therapeutic Approach for Targeting Osteosarcoma
    Jörg Fellenberg, Sarina Losch, Elena Tripel, Burkhard Lehner, Svitlana Melnik · 2023 · Cells
  11. Is Host Metabolism the Missing Link to Improving Cancer Outcomes?
    Christopher M. Wright, Anuradha A. Shastri, Emily K. Bongiorno, Ajay Palagani, Ulrich Rodeck, Nicole Lynn Simone · 2020 · Cancers
  12. Diabetes drugs and the incidence of solid cancers: a survey of the current evidence
    Marco Tuccori, Irma Convertino, Maria Teresa Galiulo, Alessandra Marino, Alice Capogrosso-Sansone, Corrado Blandizzi · 2017 · Expert Opinion on Drug Safety
  13. Biochemical and computational inhibition of α-glucosidase by novel metronidazole-linked 1 H -1,2,3-triazole and carboxylate moieties: kinetics and dynamic investigations
    Saeed Mahmud Ullah, Sobia Ahsan Halim, Muhammad Salman Waqas, Farheen Mansoor, Satya Kumar Avula, Farhan Ahmed Khan, Muhammad Perviaz, Hanan A. Ogaly, Ajmal Khan, Ahmed Al‐Harrasi · 2024 · Journal of Biomolecular Structure and Dynamics
  14. Pan‐cancer analysis and oncogenic implications of MGAM and MGAM2 : Toward precision oncology and drug repurposing in colorectal cancer
    Rawaa Chasib Mezher, Hanieh Azari, Reza Khayami, Hamid Fiuji, Farzaneh Lal Alizadeh, Ladan Goshayeshi, Majid Rajabian, Ibrahim Saeed Gataa, Seyed Mahdi Hassanian, Amir Avan · 2025 · Journal of Cell Communication and Signaling
  15. Metformin in Health Issues and Reproductive System
    Elham Pourmatroud · 2019 · IntechOpen eBooks
  16. Colorectal cancer in patients with diabetes - epidemiology, pathophysiology and applications for clinical practice
    Alexandra Romanová, Jana Malinovská, Michala Lustigová, Jana Urbanová, Ludmila Brunerová, Veronika Vejtasová, Ankita Verma, Tung A. Duong, Jan Šťovíček, Jan Brož · 2022 · Vnitřní lékařství
  17. Cyclooxygenase-2–1195G>A Polymorphism and Head and Neck Squamous Cell Carcinoma Susceptibility: A Meta-Analysis of 1564 Cases and 2346 Controls
    Donglai Deng, Lingyun Xia, Bing-Yang He, Jingmei Guo, Cui Huang, Xian‐Tao Zeng · 2015 · Medical Science Monitor
  18. Sulfonilureas. Estado actual de su empleo en América Latina. Documento de posición de la Asociación Latinoamericana de Diabetes
    Juan Rosas-Saucedo, Juan Rosas-Guzmán, José Agustín Mesa-Pérez, Manuel González-Ortı́z, Esperanza Martínez‐Abundis, Roberto González-Suárez, Isaac R. Sinay, Ruy Lyra · 2019 · Alad
  19. How Often do Medical Specialties Question the Practices that They Perform? An Empirical, Cross-Sectional Analysis of the Published Literature
    Alyson Haslam, Kerrington Powell, Vinay K. Prasad · 2022 · INQUIRY The Journal of Health Care Organization Provision and Financing
  20. Cancer Incidence and Survival Among Patients Following an Acute Coronary Syndrome
    Inbar Nardi Agmon, Gali Cohen, Osnat Itzhaki Ben Zadok, David M. Steinberg, Ran Kornowski, Yariv Gerber · 2023 · The American Journal of Cardiology
  21. Continuum of type 2 diabetes mellitus and its comorbidity with other somatic diseases
    М. Н. Мамедов, И. В. Друк, G. G. Arabidze, H. R. Akhundova · 2024 · Russian Journal of Preventive Medicine
  22. Diabetes and Cancer
    Ellena Badrick, Emily J. Gallagher, Andrew G. Renehan · 2024
  23. Bifunctional Metformin–Phenolic Hybrids with Improved Anticancer and Antioxidant Properties: Evaluation on Glioma Cells
    Caroline Delehedde, Mathieu Chocry, Camille Nguyen, Alice Asteian, Maxime Robin, Ludovic Leloup, Mathieu Cassien, Anne Mercier, Marcel Culcasi, Hervé Kovacic et al. · 2026 · International Journal of Molecular Sciences
  24. Appetite, Obesity, Metabolism, and Malignancy: Do Incretin-Mimetic Drugs Reduce Cancer Risk?
    Andrew G. Renehan, Michaël Pollak · 2026 · Cancer Prevention Research
  25. The diabetes mellitus and oncopathоlogy
    Larysa Zhuravlyova, Неля Володимирівна Сокольникова · 2021 · Medicine of Ukraine
  26. Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz
    Christian Jenssen, Cristine Pietsch · 2022 · Die Diabetologie
  27. Manipulating the hypoxic tumour microenvironment to study therapy resistance
    Jonathan Ient · 2021
  28. Association of Diabetes and Cancers: An analysis of the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP-NIS) 2005-2015 Dataset
    Shahryar Zeighami, Ali Seifi, Mohammad Hossein Sharifi, Zahra Gheibi, Alireza Rezvani, Alireza Heiran, Saba Sahraian, Hadis Salimi, Alireza Mirahmadizadeh · 2025 · Research Square
  29. Metformin: Hype or Hope for Cancer
    Aslı Nar · 2017 · International Journal of Hematology and Oncology
  30. Diabetes and Cancer
    Joanna Krajewska, Wojciech R. Krajewski, Tomasz Zatoński · 2019 · Springer eBooks
  31. Research Progress on Anti-Tumor Effect of Metformin in Gastric Cancer
    礼琴 贺 · 2019 · Advances in Clinical Medicine
  32. Diabetes
    Rachel S. Dankner · 2018 · Elsevier eBooks
  33. Metformin
    Matteo Lazzeroni, Sara Gandini · 2017 · Elsevier eBooks
  34. References
    2017 · Elsevier eBooks
  35. La terapia insulinica nel diabete mellito di tipo 2
    Anna Toffalini, Alessandro Mantovani, Giacomo Zoppini · 2022 · il Diabete
  36. Genetically-proxied anti-diabetic drug target perturbation and risk of cancer: a Mendelian randomization analysis
    James Yarmolinsky, Emmanouil Bouras, Andrei‐Emil Constantinescu, Kimberley Burrows, Caroline J. Bull, Emma E. Vincent, Richard Michael Martin, Olympia Dimopoulou, Sarah Jane Lewis, Victor Rau Moreno et al. · 2022 · medRxiv
  37. Thyroid gland cancer and insulin resistance: a modern view of the problem
    Nataliia S. Pidchenko · 2022 · Український радіологічний та онкологічний журнал
  38. Diabetes and Cancer
    Joanna Krajewska Wojciechowska, Wojciech R. Krajewski, Tomasz Zatoński, Joel Rodríguez‐Saldaña · 2023 · Springer eBooks
  39. The interplay between antidiabetic medications and cancer risk
    Duaa Durrani, Muhammad Hassan, Aimen Zulfikar · 2023 · International Journal of Scientific Reports
  40. Assessing the antitumor effects of metformin on ovarian clear cell carcinoma
    Satoshi Takemori, Tohru Morisada, Makoto Osaka, Momoe Watanabe, Atsushi Tajima, Shinji Tanigaki, Yoichi Kobayashi · 2024 · Human Cell
  41. Assessment of cancer risk associated with 7‐nitroso‐3‐(trifluoromethyl)‐5,6,7,8‐tetrahydro[1,2,4] triazolo‐[4,3‐a]pyrazine‐contaminated sitagliptin use: A retrospective cohort study
    Takehiro Sugiyama, Takashi Furuno, Yuichi Ichinose, Masao Iwagami, Noriko Ihana‐Sugiyama, Kenjiro Imai, Tamaki Kakuwa, Ryoko Rikitake, Mitsuru Ohsugi, Takahiro Higashi et al. · 2024 · Journal of Diabetes Investigation
  42. Acarbose might be associated with reduced risk of gastric cancer in patients with diabetes mellitus: A nationwide population‐based cohort study
    Pili Chih‐Min Mao, Mei‐Ing Chung, Yao‐Min Hung, Hsiu‐Min Chen, Chien‐Liang Chen · 2024 · Pharmacoepidemiology and Drug Safety
  43. Du diabète au cancer : développement d'une nouvelle famille de molécules hybrides dérivées de la metformine : synthèse et caractérisation par RPE de sondes vectorisées pour l'étude du dysfonctionnement mitochondrial
    Caroline Delehedde · 2019
  44. The therapeutic value of antidiabetic drugs in lung cancer treatment: from clinical evidence to possible mechanisms
    Q Wang, Jiayi Xu, Qing Liu, Haixia Zhou, Yue Hu · 2026 · Frontiers in Immunology